Maria T. Schmook

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Assessment of treatment response in recurrent medulloblastoma using craniospinal MRI.

Assessment of treatment response in recurrent medulloblastoma using craniospinal MRI.

Journal: European journal of radiology
Published: May 01, 2026

Postpartum pheochromocytoma crisis associated with cardiogenic shock and Sheehan's syndrome.

Postpartum pheochromocytoma crisis associated with cardiogenic shock and Sheehan's syndrome.

Journal: BMJ case reports
Published: March 19, 2025

M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumors.

M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumors.

Journal: Nature cancer
Published: March 10, 2025

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Journal: Neuro-oncology
Published: November 18, 2024

Pearls & Oy-sters: Neurologic Involvement in Shiga Toxin-Associated Hemolytic Uremic Syndrome.

Pearls & Oy-sters: Neurologic Involvement in Shiga Toxin-Associated Hemolytic Uremic Syndrome.

Journal: Neurology
Published: October 08, 2024

Developmental, Cognitive, Ocular Motor, and Neuroimaging Findings Related to SUFU Haploinsufficiency: Unraveling Subtle and Highly Variable Phenotypes.

Developmental, Cognitive, Ocular Motor, and Neuroimaging Findings Related to SUFU Haploinsufficiency: Unraveling Subtle and Highly Variable Phenotypes.

Journal: Pediatric neurology
Published: January 14, 2024

Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients.

Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients.

Journal: Pediatric blood & cancer
Published: August 29, 2023

Lethal Encephalopathy in an Infant with Hypophosphatasia despite Enzyme Replacement Therapy.

Lethal Encephalopathy in an Infant with Hypophosphatasia despite Enzyme Replacement Therapy.

Journal: Hormone research in paediatrics
Published: August 17, 2021

Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal Melanomatosis.

Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal Melanomatosis.

Journal: Journal of personalized medicine
Published: March 19, 2021

Targeting fibroblast growth factor receptors to combat aggressive ependymoma.

Targeting fibroblast growth factor receptors to combat aggressive ependymoma.

Journal: Acta neuropathologica
Published: December 22, 2020

Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma.

Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma.

Journal: Journal of personalized medicine
Published: November 18, 2020

Influence of socioeconomic status on cognitive outcome after childhood arterial ischemic stroke.

Influence of socioeconomic status on cognitive outcome after childhood arterial ischemic stroke.

Journal: Developmental medicine and child neurology
Published: November 13, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026